DK3003343T3 - Biomimetisk peptid og bionedbrydelig leveringsplatform til behandling af angiogenese- og lymfangiogeneseafhængige sygdomme - Google Patents
Biomimetisk peptid og bionedbrydelig leveringsplatform til behandling af angiogenese- og lymfangiogeneseafhængige sygdomme Download PDFInfo
- Publication number
- DK3003343T3 DK3003343T3 DK14807179.8T DK14807179T DK3003343T3 DK 3003343 T3 DK3003343 T3 DK 3003343T3 DK 14807179 T DK14807179 T DK 14807179T DK 3003343 T3 DK3003343 T3 DK 3003343T3
- Authority
- DK
- Denmark
- Prior art keywords
- lymphangiogenese
- angiogenese
- peptid
- biomimetic
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Nanotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Obesity (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361832290P | 2013-06-07 | 2013-06-07 | |
| PCT/US2014/041526 WO2014197892A1 (en) | 2013-06-07 | 2014-06-09 | A biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3003343T3 true DK3003343T3 (da) | 2020-02-03 |
Family
ID=52008639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14807179.8T DK3003343T3 (da) | 2013-06-07 | 2014-06-09 | Biomimetisk peptid og bionedbrydelig leveringsplatform til behandling af angiogenese- og lymfangiogeneseafhængige sygdomme |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9802984B2 (da) |
| EP (2) | EP3643318A1 (da) |
| JP (2) | JP6470740B2 (da) |
| CN (2) | CN110981941A (da) |
| AU (1) | AU2014274703B2 (da) |
| CA (1) | CA2914764C (da) |
| DK (1) | DK3003343T3 (da) |
| ES (1) | ES2774217T3 (da) |
| HK (1) | HK1222542A1 (da) |
| HU (1) | HUE047735T2 (da) |
| IL (1) | IL242760B (da) |
| WO (1) | WO2014197892A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014197892A1 (en) * | 2013-06-07 | 2014-12-11 | The Johns Hopkins University | A biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases |
| WO2016022947A1 (en) | 2014-08-07 | 2016-02-11 | The Johns Hopkins University | Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases |
| KR101748120B1 (ko) * | 2015-07-13 | 2017-06-16 | 서울대학교산학협력단 | 나노입자-유리체 기반 단백질 복합체를 유효성분으로 포함하는 혈관신생억제용 조성물 및 이의 용도 |
| AU2016358125A1 (en) | 2015-11-19 | 2018-07-05 | Asclepix Therapeutics, Llc. | Peptides with anti-angiogenic, anti-lymphangiogenic, and anti-edemic properties and nanoparticle formulations |
| BR112019006735A2 (pt) * | 2016-10-04 | 2019-06-25 | Asclepix Therapeutics Llc | compostos e métodos para ativação da sinalização de tie2 |
| EP3621597A4 (en) * | 2017-05-08 | 2021-06-02 | Asclepix Therapeutics, Inc. | BIODEGRADABLE MICROPARTICLE FOR THE DELAYED RELEASE OF ANTI-ANGIOGENIC PEPTIDE |
| US11674959B2 (en) | 2017-08-03 | 2023-06-13 | The Johns Hopkins University | Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors |
| US11697804B2 (en) | 2018-10-01 | 2023-07-11 | The Johns Hopkins University | Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy |
| EA202192607A1 (ru) * | 2019-03-26 | 2022-03-03 | Асклепикс Терапьютикс, Инк. | Композиции и способы для лечения глазного заболевания |
| CN113144213B (zh) * | 2021-03-23 | 2023-04-07 | 西安交通大学医学院第一附属医院 | 一种多级pH响应基因-药物共递送的纳米药物、制备方法及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007033215A2 (en) | 2005-09-12 | 2007-03-22 | The Johns Hopkins University | Compositions having antiangiogenic activity and uses thereof |
| WO2007120368A2 (en) * | 2006-01-09 | 2007-10-25 | The Regents Of The University Of California | Immunostimulatory combinations for vaccine adjuvants |
| ITMI20060625A1 (it) * | 2006-03-31 | 2007-10-01 | Istituto Naz Per La Ricerca | Peptide antiangiogenico e suoi impieghi terapeutici |
| WO2008063932A2 (en) * | 2006-11-10 | 2008-05-29 | Genentech, Inc. | Method for treating age-related macular degeneration |
| US8507434B2 (en) * | 2007-01-03 | 2013-08-13 | The Johns Hopkins University | Peptide modulators of angiogenesis and use thereof |
| JP2011519893A (ja) * | 2008-05-06 | 2011-07-14 | グラクソ グループ リミテッド | 生物活性薬の封入 |
| CA2730132A1 (en) | 2008-07-21 | 2010-01-28 | Compugen Ltd. | Novel angiopoietin derived peptides |
| US9717694B2 (en) * | 2009-05-15 | 2017-08-01 | The Johns Hopkins University | Peptide/particle delivery systems |
| IN2012DN05099A (da) | 2009-12-16 | 2015-10-09 | Brigham & Womens Hospital | |
| US20120192339A1 (en) | 2010-07-28 | 2012-08-02 | Honeywell International Inc. | Flexible Body Armor Vest with Breast Plate |
| US20120270770A1 (en) * | 2010-08-03 | 2012-10-25 | Jesse Michael Jaynes | Anti-angiogenic peptides and their uses |
| US9056923B2 (en) | 2010-12-10 | 2015-06-16 | The Johns Hopkins University | Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases |
| EP2679640B1 (en) | 2011-02-24 | 2018-11-07 | Konica Minolta, Inc. | Active ray-curable inkjet ink, and image formation method |
| WO2014066811A1 (en) | 2012-10-25 | 2014-05-01 | The Johns Hopkins University | Bioreducible poly (b-amino ester)s for sirna delivery |
| US20150272900A1 (en) | 2012-10-26 | 2015-10-01 | The Johns Hopkins University | Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics |
| WO2014197892A1 (en) * | 2013-06-07 | 2014-12-11 | The Johns Hopkins University | A biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases |
-
2014
- 2014-06-09 WO PCT/US2014/041526 patent/WO2014197892A1/en active Application Filing
- 2014-06-09 DK DK14807179.8T patent/DK3003343T3/da active
- 2014-06-09 CN CN201911163740.6A patent/CN110981941A/zh active Pending
- 2014-06-09 EP EP19195992.3A patent/EP3643318A1/en active Pending
- 2014-06-09 HU HUE14807179A patent/HUE047735T2/hu unknown
- 2014-06-09 ES ES14807179T patent/ES2774217T3/es active Active
- 2014-06-09 JP JP2016518060A patent/JP6470740B2/ja active Active
- 2014-06-09 EP EP14807179.8A patent/EP3003343B1/en active Active
- 2014-06-09 CA CA2914764A patent/CA2914764C/en active Active
- 2014-06-09 AU AU2014274703A patent/AU2014274703B2/en active Active
- 2014-06-09 CN CN201480043222.XA patent/CN105431162B/zh active Active
- 2014-06-09 US US14/896,521 patent/US9802984B2/en active Active
-
2015
- 2015-11-24 IL IL242760A patent/IL242760B/en active IP Right Grant
-
2016
- 2016-09-07 HK HK16110656.6A patent/HK1222542A1/zh unknown
-
2017
- 2017-09-22 US US15/712,890 patent/US10774112B2/en active Active
-
2019
- 2019-01-18 JP JP2019006590A patent/JP6931011B2/ja active Active
-
2020
- 2020-08-10 US US16/989,416 patent/US11981754B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10774112B2 (en) | 2020-09-15 |
| CA2914764A1 (en) | 2014-12-11 |
| CN105431162B (zh) | 2019-12-10 |
| ES2774217T3 (es) | 2020-07-17 |
| CA2914764C (en) | 2021-10-26 |
| EP3643318A1 (en) | 2020-04-29 |
| JP2016521712A (ja) | 2016-07-25 |
| HUE047735T2 (hu) | 2020-05-28 |
| EP3003343A1 (en) | 2016-04-13 |
| AU2014274703B2 (en) | 2019-07-04 |
| US11981754B2 (en) | 2024-05-14 |
| CN105431162A (zh) | 2016-03-23 |
| EP3003343A4 (en) | 2016-11-30 |
| WO2014197892A1 (en) | 2014-12-11 |
| US20180134753A1 (en) | 2018-05-17 |
| JP6470740B2 (ja) | 2019-02-13 |
| JP6931011B2 (ja) | 2021-09-01 |
| CN110981941A (zh) | 2020-04-10 |
| HK1222542A1 (zh) | 2017-07-07 |
| US20160122390A1 (en) | 2016-05-05 |
| JP2019089790A (ja) | 2019-06-13 |
| US9802984B2 (en) | 2017-10-31 |
| US20200361993A1 (en) | 2020-11-19 |
| AU2014274703A1 (en) | 2015-12-10 |
| IL242760B (en) | 2021-03-25 |
| EP3003343B1 (en) | 2019-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3003343T3 (da) | Biomimetisk peptid og bionedbrydelig leveringsplatform til behandling af angiogenese- og lymfangiogeneseafhængige sygdomme | |
| DK3350157T3 (da) | Forbindelser og sammensætninger til intracellulær afgivelse af terapeutiske midler | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3035955T3 (da) | Sammensætning og vaccine til behandling af lungekræft | |
| DK3450553T3 (da) | Mrna-terapi til behandling af øjensygdomme | |
| DK3692857T3 (da) | Indretning til levering af hudplejesammensætning | |
| DK3204095T3 (da) | Inhalationsindretning til anvendelse i aerosolbehandling af luftsvejssygdomme | |
| DK3041926T3 (da) | Indretning til in-vitro-modellering af in-vivo-væv af organer | |
| DK3068392T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme | |
| DK3328414T3 (da) | Sammensætning til anvendelse i fremme af sårheling | |
| ES2618221T8 (es) | Dispositivo de administración de prótesis vascular y método de uso | |
| DK3351239T3 (da) | Prostamid-indeholdende intraokulære implantater og fremgangsmåder til anvendelse deraf | |
| DK3234107T3 (da) | B-celler til in vivo-levering af terapeutiske midler | |
| DK3162402T3 (da) | Næsespraydyse til anvendelse i medicinsk sprøjte | |
| DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
| DK2882441T3 (da) | Behandling af immunrelaterede og inflammatoriske sygdomme | |
| DK3049117T3 (da) | Ultralydsmedieret afgivelse af lægemidler | |
| DK3169328T3 (da) | Quinolinderivater til behandling af inflammationssygdomme | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| DK2890384T3 (da) | Lægemiddelleveringsystemer og fremgangsmåder til behandling af blærekræft omfattende oxaliplatin | |
| DK3113782T3 (da) | Lægemiddelleveringssystemer og fremgangsmåder til behandling af blærekræft med gemcitabin | |
| DK3237621T3 (da) | Varianter af human alpha-galactosidase | |
| DK3164394T3 (da) | Gls1-inhibitorer til behandling af sygdomme | |
| DK3470018T3 (da) | Kryokonservering af levedygtige menneskehudssubstitutter | |
| CL2015003672A1 (es) | Fabricación de composición explosiva y plataforma de entrega, y métodos explosivos |